Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress
Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.